Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
about
Drug discovery in ophthalmology: past success, present challenges, and future opportunitiesGraves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and ManagementCurrent concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobinsIndependent adipogenic and contractile properties of fibroblasts in Graves' orbitopathy: an in vitro model for the evaluation of treatments.Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.Extrathyroidal manifestations of Graves' disease: a 2014 update.Total thyroid ablation in Graves' orbitopathy.Pathogenesis of thyroid eye disease: review and update on molecular mechanisms.Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management.News and views: at long last, an animal model of Graves' orbitopathy.Future Research in Graves' Orbitopathy: From Priority Setting to Trial Design Through Patient and Public Involvement.Genetic immunization with mouse thyrotrophin hormone receptor plasmid breaks self-tolerance for a murine model of autoimmune thyroid disease and Graves' orbitopathy.New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor.Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.
P2860
Q26771638-32FDA96B-DF3E-405F-96B2-0865ED6AB935Q26782424-A13A224A-2BB0-4964-A18F-CA7CA9296C22Q27691806-0E566C92-9DC3-4E5E-A7F4-4B11BABB5B37Q35096870-3F253F9D-180B-4A6B-94BA-AA1D01C3E65FQ35154018-386E310B-91AB-4298-BAA1-8E776ADE0042Q36314821-F9106A84-F869-48AE-8355-7E32A9DAD516Q37694296-BC9563BD-0891-40EA-A1FB-DF1EE76CC1F2Q38218911-74B38E54-98F6-4646-959F-AE510F9ACFEFQ38367695-F77B1F3B-4C72-44C0-A49F-C0173F28FA58Q38633022-421989D1-3AEE-4A61-94B2-E02B1B1C2C00Q40095263-00A07E80-8576-4675-BAA2-107333B9A846Q42562858-44FB38E5-1600-4E4E-BA4A-A5B2E44A24B1Q43165236-56884C80-07A8-4A35-B659-D80EBCE9AD15Q48147801-4A8551EF-A474-40D6-B9B8-3B92DB7602FAQ55024151-239C8E8A-B3F9-48B4-8D23-FC273FCC16E7Q55379805-09133604-34DC-45EA-B994-0BD28BE48AF3
P2860
Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Cutting edge: retrobulbar infl ...... asmid-in vivo electroporation.
@en
Cutting edge: retrobulbar infl ...... asmid-in vivo electroporation.
@nl
type
label
Cutting edge: retrobulbar infl ...... asmid-in vivo electroporation.
@en
Cutting edge: retrobulbar infl ...... asmid-in vivo electroporation.
@nl
prefLabel
Cutting edge: retrobulbar infl ...... asmid-in vivo electroporation.
@en
Cutting edge: retrobulbar infl ...... asmid-in vivo electroporation.
@nl
P2093
P356
P1433
P1476
Cutting edge: retrobulbar infl ...... asmid-in vivo electroporation.
@en
P2093
J Paul Banga
Neil Deasy
Sajad Moshkelgosha
Salvador Diaz-Cano
P304
P356
10.1210/EN.2013-1576
P407
P577
2013-07-30T00:00:00Z